secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0000950103-25-006186
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.01, 1.01, 2.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma closes acquisition of RP LLC; $200M cash, shares, and $380M debt assumed
--------------------------------------------------------------------------------

- Paid $200M cash plus 24,530,266 non-voting Class E shares; assumed RP Management's $380M term loan.
- Share consideration to Pablo Legorreta vests over 5 years; other management members vest over 10 years.
- Joinder of Royalty Pharma Holdings Ltd and RP LLC as borrowers under existing $380M term loan; RP Management released.
- Amended exchange agreement allows recipients to exchange RPH non-voting shares for Royalty Pharma Class A shares.
- Amended articles of association of Royalty Pharma plc and RPH to reflect new share classes and procedural refinements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000095010325006186/0000950103-25-006186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000095010325006186/dp228958_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-25-006186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer